Literature DB >> 8910287

The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.

M Muda1, A Theodosiou, N Rodrigues, U Boschert, M Camps, C Gillieron, K Davies, A Ashworth, S Arkinstall.   

Abstract

The mitogen-activated protein (MAP) kinase family includes extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) and p38/RK/CSBP (p38) as structurally and functionally distinct enzyme classes. Here we describe two new dual specificity phosphatases of the CL100/MKP-1 family that are selective for inactivating ERK or JNK/SAPK and p38 MAP kinases when expressed in COS-7 cells. M3/6 is the first phosphatase of this family to display highly specific inactivation of JNK/SAPK and p38 MAP kinases. Although stress-induced activation of p54 SAPKbeta, p46 SAPKgamma (JNK1) or p38 MAP kinases is abolished upon co-transfection with increasing amounts of M3/6 plasmid, epidermal growth factor-stimulated ERK1 is remarkably insensitive even to the highest levels of M3/6 expression obtained. In contrast to M3/6, the dual specificity phosphatase MKP-3 is selective for inactivation of ERK family MAP kinases. Low level expression of MKP-3 blocks totally epidermal growth factor-stimulated ERK1, whereas stress-induced activation of p54 SAPKbeta and p38 MAP kinases is inhibited only partially under identical conditions. Selective regulation by M3/6 and MKP-3 was also observed upon chronic MAP kinase activation by constitutive p21(ras) GTPases. Hence, although M3/6 expression effectively blocked p54 SAPKbeta activation by p21(rac) (G12V), ERK1 activated by p21(ras) (G12V) was insensitive to this phosphatase. ERK1 activation by oncogenic p21(ras) was, however, blocked totally by co-expression of MKP-3. This is the first report demonstrating reciprocally selective inhibition of different MAP kinases by two distinct dual specificity phosphatases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910287     DOI: 10.1074/jbc.271.44.27205

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  102 in total

1.  Suppression of Ras-induced apoptosis by the Rac GTPase.

Authors:  T Joneson; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.

Authors:  Paul E Hughes; Beat Oertli; Malene Hansen; Fan-Li Chou; Berthe M Willumsen; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

4.  Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Authors:  Li-Jin Chew; William Coley; Ying Cheng; Vittorio Gallo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 5.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

6.  c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Authors:  Qiangrong Liang; Orlando F Bueno; Benjamin J Wilkins; Chia-Yi Kuan; Ying Xia; Jeffery D Molkentin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

7.  Vegfa signals through ERK to promote angiogenesis, but not artery differentiation.

Authors:  Masahiro Shin; Timothy J Beane; Aurelie Quillien; Ira Male; Lihua J Zhu; Nathan D Lawson
Journal:  Development       Date:  2016-08-30       Impact factor: 6.868

8.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

9.  Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.

Authors:  Yuan-Yuan Zhang; Zi-Qing Mei; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

10.  Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis.

Authors:  Koji Okudela; Takuya Yazawa; Tetsukan Woo; Masashi Sakaeda; Jun Ishii; Hideaki Mitsui; Hiroaki Shimoyamada; Hanako Sato; Michihiko Tajiri; Nobuo Ogawa; Munetaka Masuda; Takashi Takahashi; Haruhiko Sugimura; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.